Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, ClearPoint Neuro Inc (NASDAQ: CLPT) closed at $13.54 down -3.70% from its previous closing price of $14.06. In other words, the price has decreased by -$3.70 from its previous closing price. On the day, 0.53 million shares were traded. CLPT stock price reached its highest trading level at $14.18 during the session, while it also had its lowest trading level at $13.49.
Ratios:
For a deeper understanding of ClearPoint Neuro Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.56 and its Current Ratio is at 6.37. In the meantime, Its Debt-to-Equity ratio is 2.25 whereas as Long-Term Debt/Eq ratio is at 2.23.
On October 24, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 12 ’25 when PTC Therapeutics, Inc. bought 894,578 shares for $16.53 per share.
BURNETT JOSEPH sold 26,463 shares of CLPT for $714,021 on Oct 10 ’25. The CEO and President now owns 217,059 shares after completing the transaction at $26.98 per share. On Oct 10 ’25, another insider, JOSEPH M BURNETT TRUST, who serves as the Affiliate of Director of the company, bought 26,463 shares for $28.96 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLPT now has a Market Capitalization of 402792096 and an Enterprise Value of 382375584. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.21 while its Price-to-Book (P/B) ratio in mrq is 24.25. Its current Enterprise Value per Revenue stands at 11.138 whereas that against EBITDA is -17.411.
Stock Price History:
The Beta on a monthly basis for CLPT is 0.92, which has changed by -0.07639837 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, CLPT has reached a high of $30.10, while it has fallen to a 52-week low of $9.76. The 50-Day Moving Average of the stock is -33.58%, while the 200-Day Moving Average is calculated to be -5.25%.
Shares Statistics:
For the past three months, CLPT has traded an average of 1.05M shares per day and 479710 over the past ten days. A total of 28.43M shares are outstanding, with a floating share count of 24.47M. Insiders hold about 13.89% of the company’s shares, while institutions hold 35.54% stake in the company. Shares short for CLPT as of 1763078400 were 2314674 with a Short Ratio of 2.20, compared to 1760486400 on 2382063. Therefore, it implies a Short% of Shares Outstanding of 2314674 and a Short% of Float of 8.430000399999999.
Earnings Estimates
Current recommendations for the stock of the company come from 2.0 analysts. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.22 and low estimates of -$0.24.
Analysts are recommending an EPS of between -$0.81 and -$0.85 for the fiscal current year, implying an average EPS of -$0.83. EPS for the following year is -$0.81, with 2.0 analysts recommending between -$0.75 and -$0.86.
Revenue Estimates
A total of 2 analysts believe the company’s revenue will be $10.05M this quarter.It ranges from a high estimate of $10.4M to a low estimate of $9.7M. As of. The current estimate, ClearPoint Neuro Inc’s year-ago sales were $7.77MFor the next quarter, 2 analysts are estimating revenue of $12.2M. There is a high estimate of $12.7M for the next quarter, whereas the lowest estimate is $11.7M.
A total of 2 analysts have provided revenue estimates for CLPT’s current fiscal year. The highest revenue estimate was $37M, while the lowest revenue estimate was $36.2M, resulting in an average revenue estimate of $36.6M. In the same quarter a year ago, actual revenue was $31.39MBased on 2 analysts’ estimates, the company’s revenue will be $55.5M in the next fiscal year. The high estimate is $57M and the low estimate is $54M.
